Loading...
Keywords
Last Name
Institution

Michael S. Silvey, DO

TitleDirector, Hemophilia Treatment Center
InstitutionChildren's Mercy Kansas City
DepartmentHematology, Oncology and BMT
Address2401 Gillham Rd
Kansas City MO 64108
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionUniversity of Missouri-Kansas City
    DepartmentPediatrics


    Collapse Biography 
    Collapse education and training
    Chicago College of Osteopathic Medicine, Downers Grove, ILDO2007
    University of Texas Health Science Center, San Antonio, TXResidency2010Pediatrics
    Children's Mercy Kansas City, Kansas City, MOFellowship2013Pediatric Hematology/Oncology

    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jaffray J, Mosha M, Branchford B, Goldenberg NA, Silvey M, Croteau SE, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Amankwah EK. Corrigendum to 'Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium' [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 - 2450]. J Thromb Haemost. 2023 Dec; 21(12):3658. PMID: 37741798.
      View in: PubMed
    2. Jaffray J, Mosha M, Branchford B, Goldenberg NA, Silvey M, Croteau SE, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Amankwah EK. Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children's Hospital Acquired Thrombosis consortium. J Thromb Haemost. 2023 09; 21(9):2441-2450. PMID: 37100395.
      View in: PubMed
    3. Silvey M, Nguyen ATH, Amankwah EK, McElwaine E, Branchford B, Stillings A, Krava E, Young G, Goldenberg N, Jaffray J. Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium. Thromb Res. 2022 12; 220:116-120. PMID: 36334398.
      View in: PubMed
    4. Jaffray J, Mahajerin A, Branchford B, Nguyen ATH, Faustino EVS, Silvey M, Croteau SE, Fargo JH, Cooper JD, Bakeer N, Zakai NA, Stillings A, Krava E, Amankwah EK, Young G, Goldenberg NA. A New Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in Critically Ill Children: A Report From the Children's Hospital-Acquired Thrombosis Consortium. Pediatr Crit Care Med. 2022 01 01; 23(1):e1-e9. PMID: 34406168.
      View in: PubMed
    5. Jaffray J, Baumann Kreuziger L, Branchford B, Wee CP, Faustino EVS, Zakai NA, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Goldenberg NA. Symptomatic pulmonary embolus after catheter removal in children with catheter related thrombosis: A report from the CHAT Consortium. J Thromb Haemost. 2022 01; 20(1):133-137. PMID: 34623749.
      View in: PubMed
    6. Dermott SM, Kucine N, Farooqi MS, Li W, Silvey M. Polycythemia vera in a 2-year-old child with a JAK2 exon 12 deletion. Pediatr Blood Cancer. 2021 07; 68(7):e28994. PMID: 33661568.
      View in: PubMed
    7. Jaffray J, Branchford B, Goldenberg N, Malvar J, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Sposto R, Ji L, Zakai NA, Faustino EVS, Stillings A, Krava E, Young G, Mahajerin A. Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium. J Pediatr. 2021 01; 228:252-259.e1. PMID: 32920105.
      View in: PubMed
    8. Repnikova E, Roberts J, Mc Dermott S, Farooqi MS, Iqbal NT, Silvey M, Nolen J, Taboada E, Li W. Clinical and molecular characterization of novel deletions causing epsilon gamma delta beta thalassemia: Report of two cases. Pathol Res Pract. 2019 Oct; 215(10):152578. PMID: 31451289.
      View in: PubMed
    9. Croteau SE, Cheng D, Cohen AJ, Holmes CE, Malec LM, Silvey M, Thornburg CD, Wheeler AP, Kouides PA, Raffini LJ, Neufeld EJ. Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia. Haemophilia. 2019 Jul; 25(4):668-675. PMID: 30993845.
      View in: PubMed
    10. Amos LE, Silvey M, Hall M, Witmer CM, Carpenter SL. Primary thromboprophylaxis in hospitalized children: A multi-center retrospective analysis. Thromb Res. 2019 Apr; 176:1-7. PMID: 30743065.
      View in: PubMed
    11. Silvey M, Hall M, Bilynsky E, Carpenter SL. Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery. Thromb Res. 2018 02; 162:15-21. PMID: 29253719.
      View in: PubMed
    12. Silvey M, Brand?o LR. Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients. Front Pediatr. 2017; 5:146. PMID: 28674685.
      View in: PubMed
    13. Silvey MS, Carpenter SL, Wicklund BM. The development of pulmonary embolus in patients with haemophilia A and high-titre inhibitors - a case series and review of the literature. Haemophilia. 2015 Mar; 21(2):e134-e136. PMID: 25643736.
      View in: PubMed
    14. Silvey M, Carpenter SL. Inherited thrombophilia in children. Curr Probl Pediatr Adolesc Health Care. 2013 Aug; 43(7):163-8. PMID: 23890023.
      View in: PubMed
    Silvey's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (63) concept(s)
    _
    Co-Authors Expand Description
    See all (3) people
    _
    Similar People Expand Description
    See all (60) people
    _